O

Orca Bio Tech Stack

Allogeneic cell therapy platform for blood cancer and autoimmune disease

Pharmaceutical Manufacturing Menlo Park, CA 201–500 employees Founded 2016 Privately Held

Orca Bio manufactures precision cell therapies for late-stage clinical development. The tech stack reveals a manufacturing-first operation: Lean Six Sigma, MES, ERP, and CMMS dominate, with NetSuite for enterprise finance. Hiring is skewed heavily toward manufacturing (18 roles) and operations (11), reflecting the capital- and compliance-intensive phase of scaling from GMP pilot to commercial production—ongoing projects span MES-ERP integration, site onboarding, and COGS analysis, while pain points cluster around multi-site GMP compliance and launch readiness.

Tech Stack 17 technologies

Core StackNetSuite Expensify Intune Lean Six Sigma CMMS Excel Navan Concur ERP MES Microsoft 365 Azure Entra ID Exchange Online SharePoint Microsoft Office Word PowerPoint

What Orca Bio Is Building

◆Challenges

Ensuring quality compliance
Maintaining gmp compliance across multiple sites
Barriers to treatment
Optimizing site engagement
Responding to emergency maintenance requests
Launch readiness
Inventory accuracy
Improving manufacturing efficiency
Ensuring process safety
Reducing costs

▲Active Projects

Continuous improvement initiatives for manufacturing processes
Site onboarding
Continuous improvement of facility standards
Commercial ordering platform
Case management sops
Atc operations
Utilization insights
Mes and erp integration
Cogs analysis for clinical and commercial products
Erp implementation and maintenance

Hiring Activity

Accelerating50 roles · 30 in 30d

Department

Manufacturing

18

Ops

11

Finance

3

Logistics

3

Sales

3

Healthcare

2

Marketing

2

Research

2

Seniority

Mid

18

Junior

11

Senior

8

Director

5

Manager

5

Intern

1

Lead

1

Staff

1

Notable leadership hires: Field Medical Affairs Director, Medical Director

Company intelligence

Find more companies like Orca Bio by tech stack, pain points and active projects

Get started free

About Orca Bio

Orca Bio develops allogeneic cell therapies—products designed to replace a patient's diseased blood and immune system with a healthy donor-derived one. The company targets blood cancer and autoimmune disease indications and employs single-cell manufacturing precision to create defined, off-the-shelf products. Based in Menlo Park, California, Orca Bio operates as a privately held company with 201–500 employees. Current operational focus spans manufacturing scale-up, facility standardization across multiple sites, and preparation for commercial launch.

HeadquartersMenlo Park, CA

Company Size201–500 employees

Founded2016

Hiring MarketsUnited States

Frequently Asked Questions

What is Orca Bio's tech stack?

Manufacturing and operations platforms dominate: Lean Six Sigma, MES (Manufacturing Execution System), ERP, CMMS, NetSuite, and Microsoft 365. The stack signals a GMP-regulated biotech operation scaling from clinical to commercial production.

What are Orca Bio's main operational challenges?

Key pain points include maintaining GMP compliance across multiple sites, ensuring quality compliance, optimizing manufacturing efficiency, inventory accuracy, and launch readiness. Active projects address MES-ERP integration, site onboarding, and continuous improvement of facility standards.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size

O

Octapharma Plasma, Inc.

Pharmaceutical Manufacturing

M

Medpace

Pharmaceutical Manufacturing

G

Galderma

Pharmaceutical Manufacturing